데이터가 없습니다.

1. Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model [ LIVER INTERNATIONAL ] - 2024.05.01
2. Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment [ ALIMENTARY PHARMACOLOGY & THERAPEUTICS ] - 2024.02.01
3. Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals [ Gut and Liver ] - 2024.01.15
4. Increased Risk of Osteoporotic Fracture in Patients With Autoimmune Hepatitis [ AMERICAN JOURNAL OF GASTROENTEROLOGY ] - 2024.01.05
5. Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide [ Clinical and Molecular Hepatology ] - 2024.01.01
6. Validation of the Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List [ Clinical Gastroenterology and Hepatology ] - 2023.12.01
7. Tenofovir Alafenamide for Multiple Drug-Resistant Chronic Hepatitis B: A 3-Year Clinical Trial [ Clinical Gastroenterology and Hepatology ] - 2023.11.01
8. Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-Based Cohort Study [ AMERICAN JOURNAL OF GASTROENTEROLOGY ] - 2023.09.01
9. Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal a-Fetoprotein Screening [ Clinical Gastroenterology and Hepatology ] - 2023.06.01
10. Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis [ AMERICAN JOURNAL OF GASTROENTEROLOGY ] - 2023.06.01
11. Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment [ Journal of Liver Cancer ] - 2023.03.04
12. The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment [ Gut and Liver ] - 2022.11.15
13. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection [ JOURNAL OF HEPATOLOGY ] - 2022.10.01
14. The impact of pylorus preservation on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy: A historical cohort study [ Journal of Hepato-Biliary-Pancreatic Sciences ] - 2022.08.01
15. Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B [ LIVER INTERNATIONAL ] - 2022.07.01
16. Identification of hepatic steatosis in living liver donors by machine learning models [ HEPATOLOGY COMMUNICATIONS ] - 2022.07.01
17. Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2022.05.08
18. Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment [ CLINICAL GASTROENTEROLOGY AND HEPATOLOGY ] - 2022.04.01
19. Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate [ CLINICAL GASTROENTEROLOGY AND HEPATOLOGY ] - 2022.02.01
20. Impact of liver cirrhosis on the clinical outcomes of patients with COVID-19: a nationwide cohort study of Korea [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2021.09.01
21. Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma [ CLINICAL AND MOLECULAR HEPATOLOGY ] - 2021.06.23
22. Comparison of Long-Term Clinical Outcomes Between Spontaneous and Therapy-Induced HBsAg Seroclearance [ HEPATOLOGY ] - 2021.06.18
23. Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea [ FRONTIERS IN MEDICINE ] - 2021.02.23
24. Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis [ Clinical Gastroenterology and Hepatology ] - 2021.02.01
25. Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection [ HEPATOLOGY ] - 2021.02.01
26. A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma [ PLoS One ] - 2020.11.11
27. Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study [ Cancers ] - 2020.07.20
28. Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma [ PLOS ONE ] - 2020.03.14
29. Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B [ AMERICAN JOURNAL OF GASTROENTEROLOGY ] - 2020.03.01
30. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis [ ALIMENTARY PHARMACOLOGY & THERAPEUTICS ] - 2019.11.01
31. Can endoscopists differentiate cytomegalovirus esophagitis from herpes simplex virus esophagitis based on gross endoscopic findings? [ MEDICINE ] - 2019.06.07
32. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country [ LIVER INTERNATIONAL ] - 2019.05.25
33. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma [ HEPATOLOGY ] - 2019.05.01
34. Risk of Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Treated with Entecavir vs Tenofovir: A Nationwide Cohort Study [ JAMA Oncology ] - 2019.01.01
35. Lamivudine: fading into the mists of time [ Clinical and Molecular Hepatology (Clin Mol Hepatol) ] - 2017.12.01
36. Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy [ JOURNAL OF INFECTIOUS DISEASES ] - 2017.11.17
37. Increasing Burden of Liver Cancer Despite Extensive Use of Antiviral Agents in a Hepatitis B Virus-Endemic Population [ HEPATOLOGY ] - 2017.11.01
38. Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients [ JOURNAL OF CARDIOVASCULAR PHARMACOLOGY ] - 2017.10.01
39. Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C [ EBioMedicine ] - 2017.02.01
40. Clinical Usefulness of Endoscopic Palliation in Patients with Biliary Obstruction Caused by Hepatocellular Carcinoma [ DIGESTION ] - 2013.10.01
41. High HBV-DNA Titer in Surrounding Liver Rather Than in Hepatocellular Carcinoma Tissue Predisposes to Recurrence After Curative Surgical Resection [ JOURNAL OF CLINICAL GASTROENTEROLOGY ] - 2012.05.01

1. 머신러닝을 이용한 만성 간질환 진단 및 장기 예후 예측모델 개발 - 2023.03.01 ~ 2024.02.29
2. 지방간 환자에서 리박트 복용이 근육량에 미치는 영향 평가를 위한 전향적, 다기관, 무작위배정, 군간 비교 임상시험 - 2022.05.30 ~ 2024.05.16
3. 최종 후보물질을 이용한 초기 임상시험 시놉시스 개발 - 2022.04.01 ~ 2023.01.31
4. 머신러닝을 이용한 만성 간질환 진단 및 장기 예후 예측모델 개발 - 2022.03.01 ~ 2023.02.28
5. 최종 후보물질을 이용한 초기 임상시험 시놉시스 개발 - 2021.10.01 ~ 2022.03.31
6. 간경변증 환자에서 대상 포진 발병 위험도 및 관련 인자에 관한 연구 - 2021.05.01 ~ 2023.04.30
7. 자가 면역성 간염 시험 대상자들에서 스테로이드 점감 이후 RO7049665가 재발까지 경과한 시간에 미치는 효과를 조사하는 이중 눈가림, 무작위 배정, 평행군, 제2상 시험 - 2021.03.11 ~ 2026.12.31
8. 머신러닝을 이용한 만성 간질환 진단 및 장기 예후 예측모델 개발 - 2021.03.01 ~ 2022.02.28
9. 간경화전 비알코올성 지방간염을 앓고 있는 환자를 대상으로 MK 3655의 유효성과 안전성을 평가하기 위한 제2b상, 무작위배정, 이중눈가림, 위약 대조 임상시험 - 2020.11.26 ~ 2023.12.12

데이터가 없습니다.

      데이터가 없습니다.

 공지